Skip navigation.

Welcome to SAfAIDS

TB, is the world’s top infectious disease killer, claiming 5 000 lives each day. The heaviest burden is carried by communities already facing socio-economic challenges such as  migrants, refugees, prisoners, ethnic minorities, miners and others working and living in risk-prone settings, and marginalized women, children and older people (WHO: 2017).

SAfAIDS news

Rapid Rises in Diagnoses in US Gay Men Concentrated in Black and Younger Men

The number of HIV diagnoses continues to rise in American gay men and other men who have sex with men (MSM), with especially rapid increases seen in young black men, according to figures released by the Centers for Disease Control and Prevention (CDC) in the June 27th edition of the Morbidity and Mortality Weekly Report.

AIDS and childhood in Southern Africa

"My sister is six years old. There are no grown-ups living with us. I need a bathroom tap and clothes and shoes. And water also, inside the house. But especially, somebody to tuck me and my sister in at night." Apiwe, aged 13. The death of a parent turns a child's life upside down, but when AIDS is the cause, the tragedy is magnified.

Officials Praise New Test for Drug-Resistant TB

A new test that can detect multiple-drug-resistant tuberculosis in two days instead of the standard two to three months promises to help significantly improve treatment and prevent the spread of the airborne infection, the World Health Organization said on Monday

TB test: Could save many lives

A new diagnostic test for active tuberculosis infection could potentially save million of lives. The test, developed by Imperial College London, has won a £10,000 award for medical innovation. By growing samples in a special liquid, and analysing them with a sophisticated microscope, the TB bacteria can be identified in days, rather than weeks.

CAMBRIDGE DECLARATION:Towards Clinical Trials for Drug-Resistant Tuberculosis, June 2008

On June 10-12, 2008, stakeholders from communities, NGOs, governments, donors, industry, and academia met in Cambridge, Massachusetts, USA, and declared the formation of a movement that advocate for more research on drug-resistant TB.

The Cambridge Declaration:Towards Clinical Trials for Drug-Resistant Tuberculosis, June 2008

 Tuberculosis Cambridge, Massachusetts, USA June 12, 2008. Because today millions of people are living with drug-resistant tuberculosis (TB), drug-resistant TB, which is transmissible and deadly, represents a public-health emergency,universal access to effective TB treatment is unachievable with current tools, inadequate treatment of drug-resistant TB leads to the emergence of extensively drug-resistant (XDR) TB, and there are huge gaps in our understanding of how to best treat drug-resistant TB, we express extreme concern that the best available treatments are of limited efficacy and are reaching only a small fraction of people who need them. The others are left to die, with no or inadequate treatment.

Syndicate content